Tourmaline Bio Inc. (TRML)
US$ 16.89-2.48%
Price Chart
Key Statistics
Market Cap
$ 388.15M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
216.81K
52W High
$ 29.79
52W Low
$ 11.56
Dividend Yield
0.00%
Beta
0.00
Technicals
50-Day MA
15.7626
200-Day MA
19.1525
52 Week High
29.788
52 Week Low
11.56
About TRML
Tourmaline Bio, Inc. operates as a clinical biotechnology company that develops medicines for patients with life-altering immune and inflammatory diseases.
Employees
74
Headquarters
New York, NY
CEO
Dr. Sandeep C. Kulkarni M.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg